학술논문

TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2017, 28 1p. Supplement: 5
Subject
Language
English
ISSN
15698041